These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 337773)

  • 1. Evaluation of an experimental anticholinergic drug, elantrine, in treating the tremor of parkinsonism.
    Rix A
    Adv Exp Med Biol; 1977; 90():277-81. PubMed ID: 337773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elantrine in the treatment of parkinsonism.
    Blonsky ER
    Neurol Neurocir Psiquiatr; 1976; 17(4):231-8. PubMed ID: 798127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The L-dopa sparing effect of G 31,406 in the treatment of parkinson's disease.
    Couto B; Oliveira C; Mattos JP; Freitas MR
    Neurol Neurocir Psiquiatr; 1976; 17(4):285-92. PubMed ID: 798128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II multiclinic study of elantrine in parkinsonism.
    Blonsky ER; Ericsson AD; McKinney AS; Rix A; Wang RI; Rimm AA
    Clin Pharmacol Ther; 1974 Jan; 15(1):46-50. PubMed ID: 4587106
    [No Abstract]   [Full Text] [Related]  

  • 5. L-dopa in Parkinsonism and the influence of previous thalamotomy.
    Hughes RC; Polgar JG; Weightman D; Walton JN
    Br Med J; 1971 Jan; 1(5739):7-13. PubMed ID: 4923653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromocriptine and levodopa (with or without carbidopa) in parkinsonism.
    Kartzinel R; TEYCHENNE P; Gillespie MM; Perlow M; Gielen AC; Sadowsky DA; Calne DB
    Lancet; 1976 Aug; 2(7980):272-5. PubMed ID: 59850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bromocryptine in levodopa response-losing parkinsonism. A double blind study.
    Jansen EN
    Eur Neurol; 1978; 17(2):92-9. PubMed ID: 344042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison between results achieved by administering L-dopa and Sinemet in parkinsonism in the light of our records].
    Szulc-Kuberska J; Niewodniczy A; Poźniak-Patewics E; Wolczyk-Orzechowska M
    Neurol Neurochir Pol; 1975; 9(5):611-5. PubMed ID: 1186952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies with bromocriptine. Part 2. Double-blind comparison with levodopa in idiopathic parkinsonism.
    Kartzinel R; Shoulson I; Calne DB
    Neurology; 1976 Jun; 26(6 PT 1):511-3. PubMed ID: 778655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacological treatment of parkinsonian tremor].
    Yokochi F
    Nihon Rinsho; 2000 Oct; 58(10):2091-5. PubMed ID: 11068452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine in the treatment of tremor.
    Pakkenberg H; Pakkenberg B
    Acta Neurol Scand; 1986 Mar; 73(3):295-7. PubMed ID: 3521185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Kr 339 in the treatment of parkinsonian tremor].
    Iivanainen M
    Duodecim; 1974; 90(8):590-6. PubMed ID: 4605767
    [No Abstract]   [Full Text] [Related]  

  • 13. Mehixene hydrochloride and parkinsonian tremor.
    Norris JW; Vas CJ
    Acta Neurol Scand; 1967; 43(4):535-8. PubMed ID: 4866169
    [No Abstract]   [Full Text] [Related]  

  • 14. Levodopa in Parkinsonism: the effects of withdrawal of anticholinergic drugs.
    Hughes RC; Polgar JG; Weightman D; Walton JN
    Br Med J; 1971 May; 2(5760):487-91. PubMed ID: 5579489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin Yahr.
    Lees AJ; Tolosa E; Olanow CW
    Mov Disord; 2015 Jan; 30(1):19-36. PubMed ID: 25488030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromocriptine: low-dose therapy in Parkinson disease.
    Teychenne PF; Bergsrud D; Racy A; Elton RL; Vern B
    Neurology; 1982 Jun; 32(6):577-83. PubMed ID: 7201089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combined administration of cholinolytic metamizil and L-Dopa in vascular parkinsonism].
    Kamenetskiĭ VK
    Klin Med (Mosk); 1978 Sep; 56(9):113-5. PubMed ID: 703225
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of Parkinson's syndrome using a new preparation from the series of tricyclic psychotropic drugs].
    Deze J; Völler GW
    Med Welt; 1975 Aug; 26(33-34):1457-62. PubMed ID: 1100988
    [No Abstract]   [Full Text] [Related]  

  • 19. Two weeks of treatment with deprenyl (selegiline) does not prolong L-dopa effect in parkinsonian patients: a double-blind cross-over placebo-controlled trial.
    Rascol O; Montastruc JL; Senard JM; Demonet JF; Simonetta M; Rascol A
    Neurology; 1988 Sep; 38(9):1387-91. PubMed ID: 3137488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of parkinsonism with l-dopa and a decarboxylase inhibitor. An electrophysiological and clinical study.
    Dietrichson P; Presthus J; Holmsen R
    Eur Neurol; 1975; 13(4):339-49. PubMed ID: 1149754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.